Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Diabetes Research and Clinical Practice
|
September 24, 2020
Use of SGLT2 inhibitors during Ramadan: An expert panel statement
Mohamed Hassanein, Alaaeldeen Bashier, Hoosen Randeree, et al.
Journal of Clinical Medicine
|
September 27, 2025
Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience
Adnan Agha, Bachar Afandi, Saeed AlKaabi, et al.
International Journal of Clinical Practice
|
August 30, 2017
Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
Mohamed Hassanein, Akram Echtay, Ahmed Hassoun, et al.
Annals of Medicine
|
April 28, 2025
Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: beyond glycemic control
Youssef M Shalaby, Mohammed Moutaz Nakhal, Bachar Afandi, et al.
Plos One
|
September 22, 2022
Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes
Raya Almazrouei, Charu Sharma, Bachar Afandi, et al.
American Journal of Translational Research
|
August 12, 2022
Relationship between lipid profile, inflammatory and endothelial dysfunction biomarkers, and type 1 diabetes mellitus: a case-control study
Juma Alkaabi, Charu Sharma, Javed Yasin, et al.
Frontiers in Endocrinology
|
November 3, 2025
Urinary C-peptide creatinine ratio as a non-invasive diagnostic tool for differentiating type 1 from type 2 diabetes mellitus in adult Emirati population: a prospective validation study
Fayez Alshamsi, Afrin Pathan, Javed Yasin, et al.
Vascular Health and Risk Management
|
March 5, 2026
Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes
Salah Abusnana, Hani Sabbour, Bachar Afandi, et al.
Primary Care Diabetes
|
March 7, 2026
Fasting with type 1 diabetes during Ramadan: Influence of insulin regimen in the DaR 2020 & 2022 global surveys
Nancy Elbarbary, Majd Aldeen Kallash, Muhammad Yaqoob Ahmedani, et al.
Annals of Human Genetics
|
September 24, 2020
Association of variants in PTPN22, CTLA-4, IL2-RA, and INS genes with type 1 diabetes in Emiratis
Charu Sharma, Bassam R Ali, Wael Osman, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Diabetes Research and Clinical Practice
|
September 24, 2020
Use of SGLT2 inhibitors during Ramadan: An expert panel statement
Mohamed Hassanein, Alaaeldeen Bashier, Hoosen Randeree, et al.
Journal of Clinical Medicine
|
September 27, 2025
Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience
Adnan Agha, Bachar Afandi, Saeed AlKaabi, et al.
International Journal of Clinical Practice
|
August 30, 2017
Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
Mohamed Hassanein, Akram Echtay, Ahmed Hassoun, et al.
Annals of Medicine
|
April 28, 2025
Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: beyond glycemic control
Youssef M Shalaby, Mohammed Moutaz Nakhal, Bachar Afandi, et al.
Plos One
|
September 22, 2022
Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes
Raya Almazrouei, Charu Sharma, Bachar Afandi, et al.
American Journal of Translational Research
|
August 12, 2022
Relationship between lipid profile, inflammatory and endothelial dysfunction biomarkers, and type 1 diabetes mellitus: a case-control study
Juma Alkaabi, Charu Sharma, Javed Yasin, et al.
Frontiers in Endocrinology
|
November 3, 2025
Urinary C-peptide creatinine ratio as a non-invasive diagnostic tool for differentiating type 1 from type 2 diabetes mellitus in adult Emirati population: a prospective validation study
Fayez Alshamsi, Afrin Pathan, Javed Yasin, et al.
Vascular Health and Risk Management
|
March 5, 2026
Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes
Salah Abusnana, Hani Sabbour, Bachar Afandi, et al.
Primary Care Diabetes
|
March 7, 2026
Fasting with type 1 diabetes during Ramadan: Influence of insulin regimen in the DaR 2020 & 2022 global surveys
Nancy Elbarbary, Majd Aldeen Kallash, Muhammad Yaqoob Ahmedani, et al.
Annals of Human Genetics
|
September 24, 2020
Association of variants in PTPN22, CTLA-4, IL2-RA, and INS genes with type 1 diabetes in Emiratis
Charu Sharma, Bassam R Ali, Wael Osman, et al.
Page
of 6